An Analysis of Drinking Motives in the Maintenance of Co-Occurring Obsessive–Compulsive Symptoms and Alcohol Misuse.

Autor: Randazza, Michael P.^1,2 (AUTHOR) randazza@uark.edu, Ham, Lindsay S.² (AUTHOR), McKay, Dean¹ (AUTHOR)

Publikováno v: Substance Use & Misuse. 2024, Vol. 59 Issue 14, p2073-2083. 11p.

ASSYST-Individual Adapted for the Treatment of Obsessive-Compulsive Disorder.

Autor: Martínez Cáceres, Gonzalo¹ (AUTHOR), Premuda-Conti, Paola² (AUTHOR) ppremudaconti@troy.edu

Publikováno v: Journal of EMDR Practice & Research. 2024, Vol. 18 Issue 3, p129-142. 14p.

High Intensive Exposure and Response Prevention in the Treatment of Obsessive-Compulsive Disorder for a 72-year-Old Man.

Autor: Gabriella Guineau, Melissa^1,2 (AUTHOR) m.guineau@propersona.nl, Oude Voshaar, Richard³ (AUTHOR), Hendriks, Gert-Jan^1,2 (AUTHOR)

Publikováno v: Clinical Case Studies. Jun2024, Vol. 23 Issue 3, p167-185. 19p.

Single‐extracellular vesicle (EV) analyses validate the use of L1 Cell Adhesion Molecule (L1CAM) as a reliable biomarker of neuron‐derived EVs.

Autor: Nogueras‐Ortiz, Carlos J¹ (AUTHOR) carlos.nogueras-ortiz@nih.gov, Eren, Erden¹ (AUTHOR), Yao, Pamela¹ (AUTHOR), Calzada, Elizabeth¹ (AUTHOR), Dunn, Christopher² (AUTHOR), Volpert, Olga³ (AUTHOR), Delgado‐Peraza, Francheska¹ (AUTHOR), Mustapic, Maja¹ (AUTHOR), Lyashkov, Alexey¹ (AUTHOR), Rubio, F Javier⁴ (AUTHOR), Vreones, Michael¹ (AUTHOR), Cheng, Lesley⁵ (AUTHOR), You, Yang^6,7 (AUTHOR), Hill, Andrew F^5,8 (AUTHOR), Ikezu, Tsuneya^6,7 (AUTHOR), Eitan, Erez³ (AUTHOR), Goetzl, Edward J^9,10 (AUTHOR), Kapogiannis, Dimitrios^1,11 (AUTHOR) kapogiannisd@mail.nih.gov

Publikováno v: Journal of Extracellular Vesicles. Jun2024, Vol. 13 Issue 6, p1-21. 21p.

The use of antipsychotics in obsessive compulsive disorder.

Autor: Conti D; Department of Mental Health, Department of Biomedical and Clinical Sciences Luigi Sacco, University of Milan, Milan, Italy., Girone N; Department of Mental Health, Department of Biomedical and Clinical Sciences Luigi Sacco, University of Milan, Milan, Italy., Boscacci M; Department of Mental Health, Department of Biomedical and Clinical Sciences Luigi Sacco, University of Milan, Milan, Italy., Casati L; Department of Mental Health, Department of Biomedical and Clinical Sciences Luigi Sacco, University of Milan, Milan, Italy., Cassina N; Department of Mental Health, Department of Biomedical and Clinical Sciences Luigi Sacco, University of Milan, Milan, Italy., Cerolini L; Department of Mental Health, Department of Biomedical and Clinical Sciences Luigi Sacco, University of Milan, Milan, Italy., Giacovelli L; Department of Mental Health, Department of Biomedical and Clinical Sciences Luigi Sacco, University of Milan, Milan, Italy., Viganò C; Department of Mental Health, Department of Biomedical and Clinical Sciences Luigi Sacco, University of Milan, Milan, Italy., Conde MM; Humanitas University, Milan, Italy., Cremaschi L; Department of Mental Health, Department of Biomedical and Clinical Sciences Luigi Sacco, University of Milan, Milan, Italy., Dell'Osso BM; Department of Mental Health, Department of Biomedical and Clinical Sciences Luigi Sacco, University of Milan, Milan, Italy.; Department of Psychiatry and Behavioral Sciences, Bipolar Disorders Clinic, Stanford University, Stanford, California, USA.; 'Aldo Ravelli' Center for Neurotechnology and Brain Therapeutic, University of Milan, Milan, Italy.

Publikováno v: Human psychopharmacology [Hum Psychopharmacol] 2024 May; Vol. 39 (3), pp. e2893. Date of Electronic Publication: 2024 Feb 10.